- BIST10011,798+3.22%
- USD49.55+0.21%
- EUR55.57-0.09%
- GOLD4,140.50-0.47%
- INTEREST37.00%-1.00
- BITCOIN82,516+0.82%
- October 20, 202621°
- BIST10011,798+3.22%
- USD49.55+0.21%
- EUR55.57-0.09%
- GOLD4,140.50-0.47%
- INTEREST37.00%-1.00
- BITCOIN82,516+0.82%
- October 20, 202621°
New Chairman of the Board Appointed at Rameda
Following the LVP Pharma investment, Rameda appointed Sharif Ahmed El Akhdar as chairman of the board. Two new board members were also added to the company.
Rameda, one of Egypt's leading pharmaceutical manufacturers, announced the appointment of Sharif Ahmed El Akhdar as chairman of the board. El Akhdar will serve representing LVP Pharma in the company.
The appointment came after LVP Pharma completed its strategic investment in Rameda. LVP Pharma operates as the investment arm of LimeVest and is part of a structure focused on the healthcare sector.
The company also announced that Dalia El Shal and Ahmed Abou Hendia were added to the board as non-independent members representing LVP Pharma. These changes were approved at the board meeting held on June 1, 2026.
The board increased to 13 members
Following the changes, Rameda's board now consists of 13 members. The structure brings together members representing the company's main shareholders and independent members.
The company stated that this arrangement reflects its approach to strengthening corporate governance and ensuring balanced representation. The new structure also reshaped the company's management framework in the post-investment period.
Growth emphasis from El Akhdar
Sharif Ahmed El Akhdar expressed his honor in taking on the role of chairman of the board at Rameda. He described the company as a resilient, well-managed pharmaceutical platform with growth potential.
El Akhdar said he aims, together with the board and senior management, to accelerate growth, deepen institutionalization, support regional expansion initiatives, and create long-term value for shareholders and patients.
Who is Sharif Ahmed El Akhdar?
Sharif Ahmed El Akhdar is the founder and chairman of LimeVest. He founded the company in 2017, chairs the investment committee, and oversees strategy, fundraising, and deal development processes.
Previously a partner at BPE Partners, El Akhdar led investments in companies such as Madinet Nasr Housing and Development, Total Egypt, PGESCo, and Pickalbatros. Earlier in his career, he worked at American Capital Strategies and began his professional journey as a management consultant at Abt Associates.
It was also announced that El Akhdar currently serves on the boards of Housing and Development Bank, Alexandria New Medical Center, Egyptian Resorts Company, and several healthcare and investment companies.
Thanks to the former chairman
The Rameda board and the incoming chairman also thanked Ayman Abbas, who stepped down. Abbas was recognized for his contributions and leadership during his tenure.
Ayman Abbas will continue as a non-independent member on the board during the transition period to maintain continuity. This way, the company will enter its new phase retaining existing management experience.
Roles of the new members
Dalia El Shal, who joined the board, serves as vice president and group financial officer at LimeVest Partners Healthcare. She manages financial strategy, portfolio operations, budgeting, treasury management, and investment review processes.
Ahmed Abou Hendia is described as the founder and managing partner of Abou-Hendia Law Firm. He is noted to have extensive corporate and legal experience with publicly traded Egyptian companies such as Elsewedy Electric, Housing and Development Bank, Egyptian Resorts Company, Arabian Cement, and Cairo Pharmaceuticals and Chemical Industries.
Rameda stated that the new management structure balances main shareholders and independent members and aligns with the company’s next growth phase. The appointments stand out as one of the first corporate steps in the new era initiated by the completion of the investment.
Sponsored Ads
Featured Listings
Loading featured properties...
Stay Updated with Ally Daily
Subscribe to be informed about special news, developments and announcements. We will keep you informed.
By signing up, you agree to our Privacy Policy
